Article

The role of NIH funding in vaccine readiness; foundational research and NIH funding underlying candidate SARS-CoV-2 vaccines

2020-09-09

Abstract excerpt

<h4>ABSTRACT</h4> This work characterizes the NIH contribution to vaccine technologies being employed in “warp speed” development of vaccines for COVID-19, as well as the lack of sustained NIH funding for published research against recognized epidemic threats. Using quantitative methods, we examined the advance of published research on ten of the vaccine technologies incorporated in the 165 candidate vaccines ente...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9cfdb293-466e-5936-aa55-7a7ca4a1e06f
DOI: 10.1101/2020.09.08.20187559

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The role of NIH funding in vaccine readiness; foundational research and NIH funding underlying candidate SARS-CoV-2 vaccinesDOI 10.1101/2020.09.08.20187559Read

SARS-CoV-2 vaccines - the biggest medical research project of the 21st century.Semantic proximity Read

Vaccines platforms and COVID-19: what you need to knowSemantic proximity Read

Living mapping review of global research funding for infectious diseases with a pandemic potential – Pandemic PACT Grant TrackerSemantic proximity Read

Translational Virology - COVID-19, The Perfect ExampleSemantic proximity Read

COVID-19 Vaccines: Where Do We Stand at the End of 2023?Semantic proximity Read

Highly Pathogenic Avian Influenza Vaccines: challenges for innovation, technological development and pandemic preparednessSemantic proximity Read

Living mapping review of global research funding for pandemic-prone infectious diseases– Pandemic PACT Grant TrackerSemantic proximity Read

Vaccines against COVID-19: Priority to mRNA-Based FormulationsSemantic proximity Read

An Overview of Vaccine Development for COVID-19Semantic proximity Read

The Allocation of US$ 105 Billion in Global Funding for Infectious Disease Research between 2000 and 2017: An Analysis of Investments from Funders in the G20 CountriesSemantic proximity Read

The Birth of the Research Field of COVID-19: Factors Determining the Evolution Supporting Discoveries and Technological Paradigm Shift with New MRNA VaccinesSemantic proximity Read

COVID-19 vaccines: breaking record times to first-in-human trialsSemantic proximity Read